Physician profile
John D Harness
NPI 1649272493
$13,628.94
in general payments reported to CMS, 2019-2025
35 companies · $1,506 in 2025
The $1,506 reported for 2025 was more than what 86% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $782 · 2021: $1,166 · 2022: $2,273 · 2023: $1,918 · 2024: $5,438 · 2025: $1,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,678 · Travel and Lodging: $2,951 · Long Term Medical Supply Or Device Loan: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,678.29 |
| Travel and Lodging | $2,951.13 |
| Long Term Medical Supply Or Device Loan | $231.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $5,595.53 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Integra Lifesciences Corporation | $3,726.20 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Koya Medical, INC. | $736.14 | 2022-2025 | Dayspring, Koya Medical, Koya Medical |
| Tactile Systems Technology INC | $662.20 | 2020-2025 | Flexitouch Plus, Nimbl |
| Smith+Nephew, INC. | $653.71 | 2019-2025 | Grafix Pl, Collagenase Santyl, Regranex |
| Organogenesis INC. | $449.58 | 2019-2022 | |
| Stryker Corporation | $353.30 | 2019-2025 | Viaflow, Allograft Bio-Implants |
| Averitas Pharma INC. | $204.52 | 2023 | Qutenza |
| Nevro Corp. | $170.49 | 2022-2024 | Senza |
| Treace Medical Concepts, INC. | $166.47 | 2023 | |
| Next Science LLC | $127.66 | 2023 | Xperience, Blastx, Surgx |
| Acera Surgical, INC. | $125.12 | 2022-2023 | Restrata Wound Matrix |
| Paratek Pharmaceuticals, INC. | $120.15 | 2023-2025 | Nuzyra |
| Biowound Solutions, INC. | $82.65 | 2025 | Bio-Connekt |
| Trice Medical, INC. | $50.00 | 2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $32.19 | 2019 | |
| Medtronic, INC. | $27.86 | 2024 | Intellis Adaptivestim |
| Ets Wound Care LLC | $27.16 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Hydrofera LLC | $25.97 | 2023 | Hydrofera Blue |
| Acell, INC. | $25.38 | 2020 | |
| Access Pro Medical, LLC | $24.82 | 2025 | Matriderm |
| Cashflow Solutions, LLC | $22.37 | 2022 | |
| Solventum Corporation | $21.31 | 2025 | Activ.A.C. |
| Orthofix Medical, INC. | $20.51 | 2019 | |
| Aroa Biosurgery Incorporated | $18.61 | 2019 | |
| Zimmer Biomet Holdings, INC. | $18.48 | 2022 | |
| Sanara Medtech INC. | $18.38 | 2024 | Celleraterx |
| Tei Medical INC. | $16.95 | 2019 | |
| Intuitive Surgical, INC. | $16.80 | 2023 | |
| Wright Medical Technology, INC. | $16.70 | 2019 | |
| Advanced Oxygen Therapy INC. | $16.22 | 2020 | |
| Merck Sharp & Dohme LLC | $16.13 | 2019 | |
| Innocoll Pharmaceuticals Limited | $16.09 | 2022 | |
| Misonix INC | $11.80 | 2019 | |
| Pfizer INC. | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Harness listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.